Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Langley

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Brachytherapy|March 27, 2024
Net survival of men with localized prostate cancer after LDR brachytherapySantiago Uribe-Lewis, Jennifer Uribe, Claire Deering, et al.
Brachytherapy|October 7, 2022
Is hemi-gland focal LDR brachytherapy as effective as whole-gland treatment for unilateral prostate cancer?Stephen Langley, Jennifer Uribe, Santiago Uribe-Lewis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancerRichard Morgan, Angela Boxall, Aagna Bhatt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 13, 2006
Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancerFerran Guedea, Ferran Aguilo, Alfredo Polo, et al.
BMJ Open|April 27, 2026
The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1-3 prostate cancerWilliam Hayhurst, Santiago Uribe-Lewis, Jennifer Uribe, et al.
European Urology Oncology|November 4, 2025
Targeted Prostate Health Checks, a Novel Screening System to Identify Men at Risk of Prostate Cancer: Real-world Evidence from More than 18 000 Prostate-specific Antigen TestsStephen Langley, Santiago Uribe-Lewis, Jennifer Uribe, et al.
World Journal of Urology|February 15, 2024
Salvage vesiculectomy for local prostate cancer recurrence: surgical technique and early post-operative outcomesAlexander Giesen, Thomas Van den Broeck, Dries Develtere, et al.
BJU International|January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPeter Grimm, Ignace Billiet, David Bostwick, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Brachytherapy|March 27, 2024
Net survival of men with localized prostate cancer after LDR brachytherapySantiago Uribe-Lewis, Jennifer Uribe, Claire Deering, et al.
Brachytherapy|October 7, 2022
Is hemi-gland focal LDR brachytherapy as effective as whole-gland treatment for unilateral prostate cancer?Stephen Langley, Jennifer Uribe, Santiago Uribe-Lewis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancerRichard Morgan, Angela Boxall, Aagna Bhatt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 13, 2006
Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancerFerran Guedea, Ferran Aguilo, Alfredo Polo, et al.
BMJ Open|April 27, 2026
The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1-3 prostate cancerWilliam Hayhurst, Santiago Uribe-Lewis, Jennifer Uribe, et al.
European Urology Oncology|November 4, 2025
Targeted Prostate Health Checks, a Novel Screening System to Identify Men at Risk of Prostate Cancer: Real-world Evidence from More than 18 000 Prostate-specific Antigen TestsStephen Langley, Santiago Uribe-Lewis, Jennifer Uribe, et al.
World Journal of Urology|February 15, 2024
Salvage vesiculectomy for local prostate cancer recurrence: surgical technique and early post-operative outcomesAlexander Giesen, Thomas Van den Broeck, Dries Develtere, et al.
BJU International|January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPeter Grimm, Ignace Billiet, David Bostwick, et al.
Pageof 3